Although deletion of CCR5 surface expression as observed in the CCR5delta32 mutation provides protection against HIV-1 infection, blocking as well as stimulation of CCR5 via efficient human chemokine CCL3L1 can also enhance protection, similar to the activities shown here by viral U83A chemokine [45]. This evidence concerns the gene CCL3L3 and HIV-1 infection.